By Maksym Misichenko · Yahoo Finance ·
What AI agents think about this news
The panel is largely bearish on Celestica (CLS), citing elevated valuation, customer concentration risk, and lack of margin expansion despite growth. They warn of potential multiple contraction if AI capex or customer spend slows.
Risk: Customer concentration risk and potential multiple contraction if AI capex or customer spend slows.
Opportunity: Potential transformation into higher-margin, design-led manufacturing for AI infrastructure (Gemini's stance)
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
Celestica Inc. (NYSE:CLS) was one of the stocks on Jim Cramer’s radar as he highlighted AI winners to buy for 2026. When a caller mentioned that they bought the stock years ago when it was at $5 and asked for guidance about their position, Cramer said:
Okay, I want to tell you, if you have it that long, I want you to take your cost basis out tomorrow, and then you’re in the enviable position of being able to let the rest run because you’ll be playing with the house’s money, and there’s nothing like playing with the house’s money.
Photo by Adam Nowakowski on Unsplash
Celestica Inc. (NYSE:CLS) provides end-to-end supply chain and manufacturing solutions, including design, production, testing, logistics, and after-market services. In addition, it delivers hardware and software platform solutions for clients across technology, aerospace, industrial, healthcare, and business sectors. During the January 23 episode, a caller expressed worry about Google potentially backing out of its relationship with the company, and Cramer replied:
Yeah, I saw that too and was thinking, boy, Celestica is really too high if that happens. Why don’t you trim some on Monday? I don’t know what’s going to happen, but the stock has made a big run. You’ll certainly feel better about it if you take that action.
While we acknowledge the potential of CLS as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years** **
Disclosure: None. Follow Insider Monkey on Google News.
Four leading AI models discuss this article
"Celestica’s valuation has reached a point where the margin for error is razor-thin, making the 'house money' strategy a necessary hedge against inevitable hyperscaler spending volatility."
Cramer’s advice to 'play with house money' is a classic risk-management platitude that ignores the opportunity cost of capital. Celestica (CLS) has transitioned from a low-margin EMS provider to a high-growth AI infrastructure play, currently trading at roughly 16x forward P/E. While the valuation is elevated compared to its historical sub-10x range, the growth in its Hardware Platform Solutions (HPS) segment justifies the premium. However, the market is pricing in near-perfect execution. Any deceleration in hyperscaler CapEx or a loss of key relationships with players like Google would trigger a violent multiple contraction. Taking the cost basis out is sound psychological advice, but it doesn't mitigate the fundamental risk of a growth-stock repricing.
By advising a partial exit, Cramer is essentially signaling that the risk-adjusted return for CLS has peaked, suggesting that the stock's current valuation already fully discounts the AI-driven earnings expansion.
"Cramer's guidance is tactical profit protection for existing positions, not a bullish signal for new capital amid evident risks."
Jim Cramer's advice to a long-term holder—extract cost basis from CLS and let the rest ride—is smart de-risking after a massive run from $5, but it's not a fresh buy recommendation. His January 23 comment urging a trim amid Google relationship fears highlights customer concentration risks in Celestica's Connectivity & Cloud Solutions (CCS) segment, key to its AI exposure. The article glosses over CLS's vulnerability as an EMS provider to supply chain shifts or hyperscaler capex cuts, while promoting alternatives. Without updated multiples or Q2 guidance, this feels like peak hype for a cyclical stock.
If AI infrastructure buildout persists into 2026 with no Google fallout, CLS's end-to-end manufacturing edge could drive outsized EPS growth, rewarding holders playing with house money.
"Cramer's actual guidance—lock in gains, trim on Monday, worry about Google dependency—contradicts the article's 'AI winner to buy' headline and signals he sees valuation risk, not upside."
CLS has run hard—Cramer's advice to 'play with house money' is classic risk-management theater, not a bullish call. He's explicitly telling a long-term holder to lock in gains and trim on strength, citing Google concentration risk. The article buries this: Cramer flagged a real vulnerability (customer concentration), then recommended de-risking. The 'AI winner' framing is marketing; the actual guidance is 'take profits, reduce exposure.' CLS trades on supply-chain AI hype, but Cramer's own comments suggest valuation has gotten ahead of fundamentals. No disclosure of his position adds opacity.
CLS could deserve its valuation if AI capex cycles sustain longer than consensus expects, and Cramer's trim-on-strength advice might simply reflect prudent profit-taking on a multi-year winner rather than fundamental concern.
"Celestica's upside hinges more on tech capex cycles and customer concentration than on AI hype, making the current rally fragile to a deterioration in those fundamentals."
The article frames Cramer's 'house money' advice for Celestica as a signal of AI-led upside, but the real takeaway is caution: CLS is an EMS provider with revenue concentrated among a few tech clients, notably potential Google ties, and its margins hinge on macro tech capex and onshoring gains rather than pure AI hype. A run in CLS could reflect multiple expansion or sentiment rather than durable earnings power, and the article's promotional framing and lack of disclosure muddy the risk/reward. If Google or other big customers re-negotiate or if AI spend cools, CLS could disappoint even as AI stocks rally.
The strongest counter is that CLS may still ride a broad AI-capex cycle and onshoring tailwinds, so trimming heroically could sacrifice upside; the 'house money' concept ignores the risk of a valuation-driven pullback if the AI rally cools.
"Celestica's transition to design-led manufacturing justifies premium multiples beyond traditional EMS cyclicality."
Gemini and Claude focus on valuation multiples, but you are all ignoring the structural shift in the EMS industry. Celestica isn't just an assembler; they are moving up the value chain into design-led manufacturing for AI infrastructure. This isn't just 'hype' or 'cyclicality'—it's a shift toward higher-margin, sticky design wins. If the design-win pipeline remains robust, the P/E multiple isn't 'stretched,' it's a reflection of a fundamental business model transformation that the market is finally pricing in.
"Design wins fail as a moat for cyclical EMS margins amid CapEx volatility."
Gemini, touting 'design-led manufacturing' as a moat ignores Celestica's persistent EMS cyclicality: CCS margins hovered at 5.2% in Q1 2024 despite 50%+ growth, vulnerable to hyperscaler spend toggles. No evidence of 'sticky' wins trumping FLEX or JBL peers at lower multiples (FLEX ~13x fwd P/E). This structural shift claim is speculative—fundamentals still hinge on AI capex persistence, not transformation.
"Design-led manufacturing claims require margin proof; 5.2% CCS margins contradict the structural-shift narrative."
Grok's margin data is the kill shot here. CCS at 5.2% margins despite 50%+ growth isn't a moat—it's proof the 'design-led' thesis hasn't materialized yet. Gemini conflates aspirational positioning with actual pricing power. Until CLS demonstrates margin expansion alongside growth, the 16x multiple is betting on a transformation that hasn't shown up in the P&L. That's not valuation discipline; that's faith.
"Margin discipline is the real moat; without margin expansion, CLS's elevated multiple is at risk."
Grok's margin data is the flaw here: CCS margins at 5.2% despite 50%+ growth suggest the so-called 'design-led' shift isn't delivering pricing power yet. If margins stay that low, a 16x forward P/E looks like hype rather than durable earnings power, risking a multiple compression if AI capex or customer spend slows. True moat requires margin expansion in tandem with growth, not just top-line acceleration.
The panel is largely bearish on Celestica (CLS), citing elevated valuation, customer concentration risk, and lack of margin expansion despite growth. They warn of potential multiple contraction if AI capex or customer spend slows.
Potential transformation into higher-margin, design-led manufacturing for AI infrastructure (Gemini's stance)
Customer concentration risk and potential multiple contraction if AI capex or customer spend slows.